Costimulatory strength influences the differential effects of transforming growth factor β1 for the generation of CD8+ regulatory T cells

被引:21
作者
Fan, Timothy M. [1 ]
Kranz, David M. [2 ]
Flavell, Richard A. [3 ]
Roy, Edward J. [4 ]
机构
[1] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA
[3] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA
[4] Univ Illinois, Dept Pathol, Sch Med, Neurosci Program, Urbana, IL 61801 USA
关键词
T cells; transcription factors; cell differentiation; costimulation; mice;
D O I
10.1016/j.molimm.2008.01.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor beta 1 (TGF beta 1) is a pleiotropic cytokine, capable of exerting diverse biologic effects. Despite its central role in multiple immune activities, the molecular signals responsible for shaping TGF beta 1's immunologic properties remain poorly elucidated. We report that costimulatory strength acts as a molecular switch, which influences the differential effects of TGF beta 1 on the effector and regulatory development of naive CD8(+) lymphocytes. At low costimulation, TGF beta 1 inhibits proliferation of CD8(+) lymphocytes and cytokine secretion, but at high costimulation the response to TGF beta 1 is quite different. High costimulation combined with TGF beta 1 generates CD8(+)CD25(+) T lymphocytes which maintain robust proliferative and survival capacity in the presence of low IL-2 concentrations. Furthermore, under these conditions, a subpopulation of CD8(+) T lymphocytes is generated that express Foxp3, secrete IL-10, and inhibit naive T lymphocyte proliferation via a contact-dependent mechanism. The adoptive transfer of these CD8(+)CD25(+)Foxp3(+) T cells into mice inoculated intravenously with B16F10 melanoma appears to accelerate tumor progression as reflected by an increase in the number of pulmonary metastatic tumor foci. These findings indicate that costimulatory strength may act as a molecular switch in the generation of CD8(+) T cells which possess a regulatory phenotype and the capacity to reduce antitumor immune responses within tumor-bearing mice. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2937 / 2950
页数:14
相关论文
共 75 条
[1]  
ABE R, 1995, J IMMUNOL, V154, P985
[2]   Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes [J].
Annunziato, F ;
Cosmi, L ;
Liotta, F ;
Lazzeri, E ;
Manetti, R ;
Vanini, V ;
Romagnani, P ;
Maggi, E ;
Romagnani, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :379-387
[3]   Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity [J].
Bienvenu, B ;
Martin, B ;
Auffray, C ;
Cordier, C ;
Bécourt, C ;
Lucas, B .
JOURNAL OF IMMUNOLOGY, 2005, 175 (01) :246-253
[4]   TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs [J].
Bisikirska, B ;
Colgan, J ;
Luban, J ;
Bluestone, JA ;
Herold, KC .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2904-2913
[5]  
BLANCKAERT VD, 1993, CANCER RES, V53, P4075
[6]  
Bright JJ, 1997, J IMMUNOL, V159, P175
[7]   ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF INTERLEUKIN-12 AGAINST MURINE TUMORS [J].
BRUNDA, MJ ;
LUISTRO, L ;
WARRIER, RR ;
WRIGHT, RB ;
HUBBARD, BR ;
MURPHY, M ;
WOLF, SF ;
GATELY, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) :1223-1230
[8]  
Cerwenka A, 1996, J IMMUNOL, V156, P459
[9]   Requirement for transforming growth factor β1 in controlling T cell apoptosis [J].
Chen, WJ ;
Jin, WW ;
Tian, HS ;
Sicurello, P ;
Frank, M ;
Orenstein, JM ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :439-453
[10]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886